Novo Nordisk mini oral: The role of oral GLP-1 RAs in the evolving landscape of obesity management
| Saturday, August 8, 2026 |
| 3:00 PM - 3:30 PM |
| Theatrette 2 (Exhibition Hall) |
Speaker
Assoc Prof Adam J Nelson
Cardiologist
Victorian Heart Institute / Royal Adelaide Hospital
The role of oral GLP-1 RAs in the evolving landscape of obesity management
3:00 PM - 3:30 PMBiography
A/Prof Adam Nelson is an early career interventional cardiologist and clinical trialist dual-appointed to the Royal Adelaide and Queen Elizabeth Hospitals in addition to the University of Adelaide and the Victorian Heart Institute. Adam has a specific interest in understanding the barriers to vaccination of cardiovascular patients and developing implementation programs to overcome them.
